GO:0031295 T cell costimulation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031295 T cell costimulation is the antigen-independent second signal delivered by surface receptor-ligand pairs that augments T cell receptor (TCR) activation.
• Costimulatory signals determine T cell fate: they can drive effector differentiation, memory formation, or regulatory T cell (Treg) induction depending on the receptor-ligand context.
• Key costimulatory receptor families include CD28/B7, TNFR superfamily members (4-1BB, CD27, GITR), and CD6, each recruiting distinct signaling adaptors.
• Costimulation is a validated therapeutic axis: agonist antibodies (e.g., 4-1BB, GITR) boost antiviral and antitumor immunity, while blockade (e.g., CD28/B7) controls autoimmunity and transplant rejection.
• Pathogens can subvert costimulation: cowpox virus encodes a protein that binds B7.1 and B7.2 to evade T cell activation.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of costimulatory genes in primary human and mouse T cells.
Description
T cell costimulation (GO:0031295) is the process by which surface-bound receptor-ligand pairs deliver a second, antigen-independent signal that augments T cell activation initiated by the T cell receptor (TCR). Without costimulation, TCR engagement alone often leads to anergy, exhaustion, or apoptosis, making costimulation a central checkpoint in adaptive immunity. The term encompasses a diverse set of receptor-ligand interactions, including CD28 binding to B7.1/B7.2, 4-1BB (TNFRSF9) binding to 4-1BBL, CD27 binding to CD70, GITR binding to GITRL, and CD6 binding to ALCAM, each of which recruits distinct signaling adaptors and downstream pathways. Because costimulatory signals shape effector versus regulatory T cell outcomes, they are intensively studied in cancer immunotherapy, chronic viral infection, autoimmunity, and transplantation. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0031295, its molecular players, disease relevance, and experimental strategies for functional validation.
T cell costimulation At A Glance
| GO ID | GO:0031295 |
|---|---|
| GO term | T cell costimulation |
| Ontology | biological_process |
| Synonym | T cell co-stimulation; T-cell co-stimulation; T-cell costimulation; T lymphocyte costimulation; T-lymphocyte costimulation |
| Major function | Provides a second, antigen-independent signal via surface receptor-ligand pairs to augment T cell receptor-driven activation |
| Key receptor families | CD28/B7, TNFR superfamily (4-1BB, CD27, GITR), CD6/ALCAM, CD9 |
| Cellular context | T cells interacting with antigen-presenting cells or target cells |
| Disease relevance | Cancer immunotherapy, chronic viral infection, autoimmunity, transplant rejection |
What Is GO:0031295?
According to the Gene Ontology, T cell costimulation (GO:0031295) is the process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent signal in addition to that provided by the T cell receptor to augment T cell activation. In other words, it is the accessory signaling input that lowers the threshold for T cell activation, sustains signaling, and instructs differentiation, without itself being the antigen-specific recognition event.
Why Is T cell costimulation Important in Cell Biology?
T cell costimulation is a decisive checkpoint that converts a transient TCR signal into a productive immune response, and its manipulation has direct therapeutic consequences. Agonist costimulation of 4-1BB or GITR can rescue exhausted T cells and resolve chronic viral infection, whereas blockade of CD28/B7 signaling can spare regulatory T cells and inhibit autoimmunity. Because costimulatory pathways are also exploited by pathogens for immune evasion, understanding GO:0031295 is essential for vaccine design, cancer immunotherapy, and tolerance induction.
• Determines whether TCR engagement leads to activation, anergy, or exhaustion.
• Controls effector and memory CD8 T cell differentiation during acute and persistent viral infection.
• Supports regulatory T cell induction and maintenance, influencing autoimmunity.
• Is a target for cancer immunotherapy agonists such as 4-1BB and GITR.
• Is a target for immunosuppression via costimulation blockade in autoimmunity and transplantation.
• Can be subverted by viral immunoevasins that bind B7.1/B7.2.
• Provides a mechanism to fine-tune T cell sensitivity to antigen dose.
• Offers biomarkers and targets for chronic viral infection and cancer.
What Happens During T cell costimulation?
TCR signal 1 and the need for signal 2
In simple terms: The T cell receptor gives the first signal, but without a second signal the T cell may not fully activate.
T cell activation begins when the TCR engages peptide-MHC, delivering signal 1. Costimulation provides signal 2 via surface receptor-ligand pairs, which is antigen-independent and augments activation. In the absence of costimulation, TCR engagement can lead to exhaustion or anergy, as observed with tonic signaling of chimeric antigen receptors.
CD28/B7 engagement and downstream signaling
In simple terms: CD28 on T cells binds B7 molecules on antigen-presenting cells to amplify activation.
CD28 binding to B7.1 (CD80) or B7.2 (CD86) is a canonical costimulatory interaction that lowers the activation threshold and promotes IL-2 production and survival. Cowpox virus encodes a protein that binds B7.1 and B7.2 to subvert this costimulation, demonstrating its importance in antiviral immunity.
TNFR superfamily costimulation: 4-1BB, CD27, GITR
In simple terms: Other receptors like 4-1BB, CD27, and GITR provide additional costimulatory signals that shape T cell fate.
4-1BB (TNFRSF9) costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection. GITR-mediated costimulation enhances CD8 T cell responses and resolves chronic viral infection.
CD6 and CD9 as alternative costimulatory receptors
In simple terms: CD6 and CD9 are additional receptors that can costimulate T cells through distinct mechanisms.
T cell costimulation by CD6 is dependent on bivalent binding of a GADS/SLP-76 complex, linking CD6 to the adaptor machinery that propagates TCR signals. CD9 synergizes with CD28 to costimulate naive T-cell activation, broadening the repertoire of costimulatory interactions.
Costimulation and regulatory T cell induction
In simple terms: Costimulatory signals can also promote regulatory T cells that suppress immune responses.
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity, showing that costimulatory pathways influence Treg homeostasis. TGF-beta induction of Foxp3 converts peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells, a process that can be modulated by costimulatory context.
Key Genes Involved in GO:0031295 T cell costimulation
The following genes encode receptors, ligands, and signaling adaptors that mediate or regulate T cell costimulation (GO:0031295).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD28 | Canonical costimulatory receptor binding B7.1/B7.2 | Target for costimulation blockade in autoimmunity |
| CD80 | Ligand (B7.1) for CD28 and CTLA-4 | Viral immunoevasin target; APC-side costimulation |
| CD86 | Ligand (B7.2) for CD28 and CTLA-4 | Viral immunoevasin target; APC-side costimulation |
| TNFRSF9 (4-1BB) | TNFR superfamily costimulatory receptor | Agonist ameliorates CAR T cell exhaustion |
| CD27 | TNFR superfamily costimulatory receptor | Controls T cell immunity in CMV infection |
| CD70 | Ligand for CD27 | Costimulation during persistent viral infection |
| TNFRSF18 (GITR) | TNFR superfamily costimulatory receptor | Enhances CD8 T cell responses in chronic infection |
| CD6 | Scavenger receptor family costimulatory receptor | Bivalent GADS/SLP-76 binding for costimulation |
| ALCAM | Ligand for CD6 | CD6-ALCAM costimulatory axis |
| CD9 | Tetraspanin costimulatory molecule | Synergy with CD28 in naive T-cell activation |
| GADS (GRAP2) | Adaptor protein recruited by CD6 | Required for CD6 costimulation |
| SLP-76 (LCP2) | Adaptor protein in TCR signaling | Bivalent binding by CD6 complex |
| FOXP3 | Transcription factor for regulatory T cells | TGF-beta-induced Treg conversion |
| IL2 | T cell growth factor | Combined with costimulation blockade for Treg sparing |
| CTLA-4 | Inhibitory receptor competing with CD28 | Endogenous regulator of costimulation |
How Is T cell costimulation Regulated?
T cell costimulation is regulated at multiple levels. CTLA-4 competes with CD28 for B7 ligands and delivers inhibitory signals, thereby setting the threshold for costimulation. Costimulation blockade combined with IL-2 can spare regulatory T cells, indicating that cytokine signals modulate the outcome of costimulatory input. Tonic signaling of chimeric antigen receptors can induce exhaustion that is ameliorated by 4-1BB costimulation, showing that the strength and quality of costimulatory signals are actively regulated. Viral proteins such as the cowpox B7-binding protein can sequester B7 ligands and subvert costimulation, representing an extrinsic regulatory mechanism.
T cell costimulation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFRSF9 (4-1BB) | CAR T cell exhaustion in cancer | Knockout or overexpression in CAR T cells |
| CD27 | Cytomegalovirus infection | Knockout mice or human T cells |
| TNFRSF18 (GITR) | Chronic viral infection | Agonist antibody in mouse models |
| CD28 | Autoimmunity and transplant rejection | Costimulation blockade in mouse models |
| CD6 | T cell activation in autoimmunity | Knockout or point mutation in T cells |
Cancer immunotherapy and T cell exhaustion
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors, supporting the use of costimulatory domains in CAR T cell design. GITR-mediated costimulation enhances CD8 T cell responses and can resolve chronic viral infection, with implications for cancer immunotherapy.
Chronic viral infection
CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection, highlighting its role in antiviral immunity. GITR costimulation also resolves chronic viral infection by enhancing CD8 T cell responses.
Autoimmunity and transplantation
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity, suggesting therapeutic strategies for autoimmune diseases. TGF-beta induction of Foxp3 converts naive T cells to regulatory T cells, a pathway relevant to tolerance induction.
Viral immune evasion
Cowpox virus encodes a protein that binds B7.1 and B7.2 and subverts T cell costimulation, providing a mechanism of immune evasion that may inform vaccine design.
From T cell costimulation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a costimulatory receptor impair T cell activation? | Knockout cell model (e.g., CD28, 4-1BB KO) |
| Does a specific point mutation in CD6 alter GADS/SLP-76 binding? | Point-mutation knock-in |
| Can a costimulatory ligand be tagged for imaging? | Tagged knock-in (e.g., CD70-GFP) |
| Does overexpression of 4-1BB enhance CAR T cell persistence? | Overexpression cell model |
| Can costimulation blockade spare Tregs? | Knockout or blocking antibody in primary T cells |
| Does viral B7-binding protein inhibit costimulation? | Overexpression of viral protein in APCs |
How to Study the T cell costimulation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface receptor expression and intracellular phospho-signaling | Assess costimulation in primary T cells |
| CRISPR knockout screen | Genes required for costimulation-dependent activation | Discovery of novel costimulatory regulators |
| Immunoprecipitation-mass spectrometry | Protein-protein interactions of costimulatory receptors | Map CD6-GADS-SLP-76 complex |
| RNA-seq | Transcriptional changes after costimulation | Identify downstream gene programs |
| In vivo viral infection model | T cell expansion and viral clearance | Test CD27 or GITR costimulation |
| Autoimmunity model | Disease incidence and Treg frequency | Evaluate costimulation blockade |
| CAR T cell assay | Exhaustion markers and persistence | Optimize 4-1BB costimulatory domain |
Flow cytometry and phospho-signaling
Flow cytometry can measure costimulatory receptor expression and downstream phosphorylation events (e.g., phospho-ERK, phospho-AKT) after receptor engagement, enabling functional assessment of costimulation in primary T cells.
CRISPR screens and functional genomics
Pooled CRISPR knockout screens can identify genes required for costimulation-dependent T cell activation, proliferation, or cytokine production, providing unbiased discovery of costimulatory pathways.
Proteomics and immunoprecipitation
Affinity purification coupled with mass spectrometry can map the interactome of costimulatory receptors such as CD6 and its adaptors GADS and SLP-76, revealing bivalent binding mechanisms.
In vivo infection and autoimmunity models
Mouse models of cytomegalovirus infection, chronic viral infection, and autoimmunity allow testing of costimulatory agonists or blockade on T cell responses and disease outcomes.
How CRISPR Can Be Used to Study GO:0031295 T cell costimulation
Knockout
CRISPR knockout of costimulatory receptors such as CD28, TNFRSF9 (4-1BB), CD27, or TNFRSF18 (GITR) in primary T cells or cell lines can determine their requirement for T cell activation, proliferation, and cytokine production.
Point Mutation
Point mutations can be introduced into costimulatory receptor cytoplasmic domains or adaptor binding sites (e.g., CD6 residues required for GADS/SLP-76 binding) to dissect signaling motifs without abolishing surface expression.
Knock-in
Knock-in of fluorescent or epitope tags (e.g., CD70-GFP) allows tracking of costimulatory ligand expression and trafficking in antigen-presenting cells or target cells.
Overexpression
Overexpression of costimulatory ligands (e.g., B7.1, B7.2, 4-1BBL) or receptors in cell models can enhance or reconstitute costimulation and test sufficiency in activation assays.
How EDITGENE Supports T cell costimulation Research
Researchers studying T cell costimulation-related genes often need to determine whether a candidate gene is causally involved in T cell activation, exhaustion, or tolerance. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for T cell costimulation research.
Frequently Asked Questions About T cell costimulation
What is T cell costimulation (GO:0031295)?
T cell costimulation is the antigen-independent second signal delivered by surface receptor-ligand pairs that augments T cell receptor activation.
What genes are involved in T cell costimulation?
Key genes include CD28, CD80, CD86, TNFRSF9 (4-1BB), CD27, CD70, TNFRSF18 (GITR), CD6, ALCAM, CD9, GADS, and SLP-76.
Why is T cell costimulation important for cancer immunotherapy?
Costimulatory domains such as 4-1BB ameliorate T cell exhaustion in CAR T cells, improving persistence and antitumor activity.
How does CD28 costimulation work?
CD28 on T cells binds B7.1 (CD80) or B7.2 (CD86) on antigen-presenting cells, lowering the activation threshold and promoting IL-2 production.
What is the role of CD27-CD70 costimulation?
CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.
Can costimulation blockade treat autoimmunity?
Costimulation blockade combined with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity in preclinical models.
How do viruses evade T cell costimulation?
Cowpox virus encodes a protein that binds B7.1 and B7.2, subverting T cell costimulation and immune activation.
What experimental models are used to study T cell costimulation?
Knockout, point-mutation, knock-in, and overexpression cell models, as well as in vivo infection and autoimmunity models, are commonly used.
What is the role of CD6 in T cell costimulation?
CD6 costimulation depends on bivalent binding of a GADS/SLP-76 complex, linking it to TCR signaling adaptors.
How can CRISPR screens identify costimulation regulators?
Pooled CRISPR knockout screens can uncover genes required for costimulation-dependent T cell activation and cytokine production.
Conclusion
GO:0031295 T cell costimulation is a central biological process that shapes T cell activation, differentiation, and tolerance. Its molecular players, from CD28/B7 to TNFR superfamily members and CD6, offer numerous targets for immunotherapy, antiviral strategies, and autoimmune disease intervention. CRISPR-based knockout, knock-in, point-mutation, and overexpression models provide the causal evidence needed to translate costimulatory biology into clinical applications.
References
- 1. Long AH et al.. 2015. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.. Nat Med 21(6):581-90 PMID: 25939063
- 2. Wang CJ et al.. 2022. Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity.. Nat Commun 13(1):6757 PMID: 36347877
- 3. Breuning J et al.. 2017. T Cell Costimulation by CD6 Is Dependent on Bivalent Binding of a GADS/SLP-76 Complex.. Mol Cell Biol 37(11) PMID: 28289074
- 4. Welten SP et al.. 2013. CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.. J Virol 87(12):6851-65 PMID: 23576505
- 5. Chen W et al.. 2003. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.. J Exp Med 198(12):1875-86 PMID: 14676299
- 6. Toyo-oka K et al.. 1997. Synergy between CD28 and CD9 costimulation for naive T-cell activation.. Immunol Lett 58(1):19-23 PMID: 9436464
- 7. Pascutti MF et al.. 2015. Enhanced CD8 T cell responses through GITR-mediated costimulation resolve chronic viral infection.. PLoS Pathog 11(3):e1004675 PMID: 25738498
- 8. Wang X et al.. 2019. Cowpox virus encodes a protein that binds B7.1 and B7.2 and subverts T cell costimulation.. Proc Natl Acad Sci U S A 116(42):21113-21119 PMID: 31575740
